A phase I trial of tocoferol monoglucoside in patients undergoing hemi-body radiation.

Purpose: To evaluate Tocoferol monoglucoside (TMG), a water soluble vit. E. in a phase I trial, as a radiation protector in those undergoing hemi-body radiation for disseminated disease.